English
FIV AB + FELV AG Rapid Test: Feline Virus Guide | Quicking Biotech
Created on 09.29
FIV AB + FELV AG Rapid Test: A Complete Guide for Cat Owners and Veterinarians
Introduction
Feline medicine faces two of its most persistent viral challenges in feline immunodeficiency virus and feline leukemia virus, and both can quietly reshape a cat's health long before obvious illness appears. Because early clinical signs are vague and easily mistaken for ordinary stress or minor infection, veterinarians rely on structured screening rather than waiting for a crisis. Rapid point-of-care testing has changed this landscape by delivering actionable results during the same appointment in which the sample is collected. The FIV AB + FELV AG rapid test is one of the most practical tools available for that purpose, combining two critical assays in a single device. Owners benefit from faster answers, shelters benefit from faster decisions, and clinics benefit from streamlined workflows. This guide explains the science, the procedure, and the clinical reasoning behind combined FIV antibody and FeLV antigen testing.
Quicking Biotech Co., Ltd has built its reputation on accessible diagnostics, and its veterinary line reflects that mission clearly. Founded in 2006, the company develops rapid detection products from its Shanghai facilities and distributes them to partners worldwide. Its catalog covers pet testing, livestock screening, and food safety, so clinics can consolidate suppliers without sacrificing breadth. Readers who want the broader picture can visit Home to see the full portfolio, or read About Us for the company's research and quality story. For animal-specific assays, the dedicated New Page highlights how the veterinary range is organized. This combination of manufacturing depth and product breadth is why the FIV AB + FELV AG rapid test fits comfortably into routine practice.
Feline Immunodeficiency Virus (FIV): Causes and Risks
FIV belongs to the lentivirus family, a group known for slow, progressive infections that unfold over years rather than days. Once inside the body, the virus preferentially targets CD4+ T lymphocytes and gradually depletes the cells that coordinate immune defense. Because this decline is gradual, an infected cat may appear completely healthy for a long period. The immune system weakens not because the virus destroys it overnight, but because it steadily erodes the body's ability to mount a coordinated response. Over time, this leaves the cat vulnerable to opportunistic bacteria, fungi, and other viruses that a healthy immune system would normally control. That slow-burning pattern is exactly why antibody screening matters, because it can identify exposure long before the animal looks unwell.
Transmission occurs most efficiently through deep bite wounds, which is why free-roaming, territorial, and fighting cats carry the highest risk. Blood contact, including shared needles or contaminated instruments, can also spread the virus in rare circumstances. Clinically, FIV-positive cats may present with persistent fever, progressive weight loss, gingivitis, stomatitis, and recurring infections of the skin, urinary tract, or respiratory system. Neurological abnormalities and certain cancers appear in a smaller proportion of cases. Because the virus itself is difficult to isolate from blood in routine practice, veterinarians detect the host's antibody response instead. Antibodies are reliable markers for FIV AB in most adult cats, which makes serology the practical diagnostic route.
Feline Leukemia Virus (FeLV): Causes and Risks
FeLV is a retrovirus that spreads far more easily than FIV and can be transmitted through casual, friendly contact between cats. It suppresses immunity, causes anemia, and is linked to lymphoma and leukemia in a significant number of persistently infected cats. The virus replicates in lymphoid tissue and bone marrow, where it can disrupt the production of healthy blood cells. Some cats manage to clear the infection, but others become persistently viraemic and remain a source of infection to other cats. Progressive infection carries a substantially shortened life expectancy, which is why identification is so important. The earlier the status is known, the better the options for monitoring and management.
Saliva is the primary vehicle, and grooming, shared food bowls, water dishes, and mutual licking all facilitate spread. Mother-to-kitten transmission occurs both in utero and through nursing, and kittens are especially susceptible to establishing lifelong infection. Clinical signs include pale mucous membranes from anemia, jaundice, lethargy, poor appetite, and unexplained weight loss. Enlarged lymph nodes, fever, and secondary infections are common, and tumors may develop later in the disease course. Unlike FIV, FeLV is diagnosed by detecting viral antigen rather than host antibody. Detecting FELV AG in serum, plasma, or whole blood indicates that viral protein is present, which correlates closely with active infection.
Why Use an FIV AB + FELV AG Combo Rapid Test?
Combining both assays on one device means a single sample yields two clinically meaningful answers. Instead of running separate FIV AB and FELV AG tests, the clinician performs one preparation and one incubation cycle. That saves time in a busy appointment and reduces the volume of blood drawn from a small, young, or stressed patient. In shelters, where dozens of cats may be screened in a single day, the efficiency gain is substantial. Fewer steps also mean fewer opportunities for procedural error at the bench. The result is a faster decision about isolation, adoption, or treatment planning.
The test accepts whole blood, plasma, or serum, so it adapts to the sample type already available in the clinic. That flexibility matters when a veterinarian has collected blood for a complete blood count and wants to add infectious disease screening without a second venipuncture. Multi-cat households benefit because a single visit can establish the status of several animals in one workflow. Shelters and catteries benefit because rapid results inform intake and quarantine policies the same day. To see how this assay sits alongside other veterinary diagnostics, browseProducts for the full catalog. Every additional screening tool strengthens the clinic's ability to catch disease earlier.
How the FIV AB + FELV AG Rapid Test Works
The device is built on immunochromatographic technology, the same lateral-flow principle used in many modern point-of-care assays. A sample migrates along a membrane where immobilized reagents capture specific targets. For FIV, the captured target is feline antibody against the virus; for FeLV, it is viral antigen circulating in the bloodstream. Captured material produces a visible colored line at the corresponding position on the strip. The control line confirms that the sample flowed correctly and that the reagents remain functional. A single test therefore reports two independent results with one visual read.
Well-designed veterinary lateral-flow tests for FIV AB achieve high sensitivity and specificity, and reputable FeLV AG assays perform comparably when used as directed. Exact figures vary by manufacturer and study design, so clinics should review the product insert and validate performance in their own caseload. Kits typically include the sealed test device, an assay diluent, an anticoagulant tube, and a capillary tube for precise sample transfer. The anticoagulant tube helps prevent clotting when whole blood is used as the specimen. Preparing all components on a clean, level surface before starting keeps the procedure orderly and repeatable. Careful attention to these details protects both accuracy and operator safety.
Step-by-Step Testing Procedure
Collect a small blood sample using the supplied capillary tube, following the fill line indicated in the instructions. If serum or plasma is preferred, separate it according to standard laboratory practice before testing. Add the sample to the designated well on the test device, then add the assay diluent in the volume specified by the manufacturer. Timing between these steps matters, so read the insert carefully and prepare everything in advance. Avoid touching the membrane area or letting the device tip during handling. Consistent technique is the simplest way to protect accuracy.
Allow the device to develop for the incubation time stated in the instructions, which is usually measured in minutes rather than hours. Read the result within the recommended window; lines that appear after that window should not be interpreted. A valid run always shows a control line, and its absence invalidates the test regardless of other lines. Dispose of used devices, tubes, and tips as biohazardous waste according to local regulations. Wash hands and disinfect the work surface after handling blood products. Documenting lot number, date, and operator supports traceability if results are ever questioned later.
Interpreting FIV AB + FELV AG Results
A positive FIV AB line indicates the presence of antibody against feline immunodeficiency virus. A positive FELV AG line indicates circulating viral antigen and points toward active infection. A negative result on either channel means the corresponding marker was not detected at the assay's limit of detection. An invalid result is one with no control line, and it requires a repeat test with a fresh device. Multiple faint lines should be interpreted with reference to the insert rather than guesswork. Recording each channel separately prevents the two results from being conflated in the medical record.
Two situations deserve special caution, and the first is the young kitten. Maternal antibodies can persist for several weeks, producing a positive FIV AB result in a kitten that is not actually infected. The second is vaccination, because some FIV vaccines can induce antibodies that interfere with antibody-based tests. FeLV antigen positives also warrant confirmation, since transient antigenemia can occur shortly after exposure before the cat clears the virus. Discordant results between a screening test and clinical signs should trigger additional diagnostics rather than a final verdict. Good interpretation pairs the test strip with history, physical examination, and follow-up testing.
Clinical Follow-Up and Retesting Guidelines
For FIV, retesting six to eight weeks after a known or suspected exposure helps distinguish true infection from a transient or false-positive result. Cats in the acute phase may not yet have seroconverted, so early negatives should be revisited. A confirmed positive cat should be monitored with regular physical examinations and bloodwork. For FeLV, follow-up testing at least ninety days after the initial test or exposure is standard practice. This interval allows the cat's immune system time either to clear the virus or to establish persistent infection. Retesting with the same assay type improves consistency between results.
Kittens under six months require particular patience because passive antibodies can persist for up to twelve weeks. Retesting after eight to twelve weeks gives a clearer picture of the kitten's true status. When results remain ambiguous, polymerase chain reaction testing can detect viral nucleic acid and add useful information. PCR is especially helpful for resolving discordant serology or confirming infection in unusual cases. Proviral PCR detects integrated viral DNA, while viral RNA PCR reflects active replication. Choosing the right confirmatory method depends on the clinical question being asked.
Prevention and Management of FIV and FeLV
Prevention starts with reducing exposure, and the single most effective step is keeping cats indoors or in secure outdoor enclosures. Vaccination against FeLV is widely used and reduces risk, though it does not eliminate it entirely. FIV vaccines exist in some markets but are not universally available and can complicate antibody testing. Testing every new cat before introduction to a household prevents the most common route of spread. Neutering reduces roaming and fighting, which lowers bite-wound transmission of FIV. Eliminating shared food and water bowls between untested cats further limits FeLV spread.
Managing a positive cat focuses on quality of life rather than cure, because neither virus can be eliminated from the body. Good nutrition, parasite control, dental care, and stress reduction all support immune function. Regular veterinary checks, typically every six months, allow early intervention when secondary problems appear. Positive cats should be kept separate from uninfected cats or housed only with other positive cats. In shelters and catteries, cohorting by status and disinfecting shared surfaces reduces transmission risk. Clear protocols for intake testing make these measures practical rather than aspirational.
Quicking Biotech FIV AB + FELV AG Rapid Test: Product Highlights
The Quicking Biotech FIV AB + FELV AG rapid test is designed as a one-step, quick, and accurate screening tool for veterinary point-of-care use. It delivers high sensitivity and specificity when handled according to the instructions. The device format is straightforward, requiring minimal equipment beyond the kit itself. Results are available within minutes, which supports same-visit clinical decisions. The test is suitable for individual clinics as well as high-volume shelter environments. Consistent manufacturing standards help ensure reproducible performance across lots.
Ordering information, bulk pricing, and distributor inquiries are handled directly by the Quicking Biotech team. Clinics expanding their diagnostic menu can review recent company updates on News to see how the veterinary portfolio is developing. For inquiries about rapid diagnostic solutions, the New Page contact form routes messages to the appropriate department. The company also supports partners with documentation, training materials, and technical guidance. Reliable supply matters in veterinary diagnostics, and a manufacturer with global reach can help maintain it. For the full range of animal disease assays, the dedicated New Page offers a consolidated view.
Conclusion
Early detection of FIV and FeLV gives cats the best chance at longer, more comfortable lives. It also protects other cats in the household, the shelter, or the cattery. Rapid combined testing puts that information in the veterinarian's hands during the appointment rather than days later. Quicking Biotech Co., Ltd continues to supply dependable FIV AB + FELV AG rapid tests to veterinary practices worldwide. Visitors can explore the full product range on Home and reach out for product details, bulk orders, or distributor inquiries. Better testing leads to better feline health outcomes, one patient at a time.
Frequently Asked Questions (FAQ)
Can the FIV AB + FELV AG rapid test be used on kittens?
Yes, the test can be used on kittens, but results must be interpreted cautiously. Kittens under six months may carry maternal antibodies that produce a positive FIV AB result without true infection. For FeLV, antigen detection in young kittens is more suggestive of infection, though transient exposure still warrants retesting. A kitten that tests positive should be retested after eight to twelve weeks before a final status is assigned.
Does vaccination affect FIV AB + FELV AG test results?
FIV vaccination can induce antibodies that some FIV AB assays will detect, producing a false-positive appearance. This is one reason vaccination history must be recorded before testing. FeLV vaccines do not generally interfere with antigen-based FELV AG detection. Clinics using FIV AB + FELV AG rapid tests should note vaccine dates in the medical record to aid interpretation.
How soon after exposure can FIV or FeLV be detected by the FIV AB + FELV AG test?
FeLV antigen can often be detected within a few weeks of exposure because the virus circulates and replicates quickly. FIV antibody, by contrast, may take several weeks to appear, so a test performed too early can be negative. Retesting six to eight weeks after suspected FIV exposure is common practice. The FIV AB + FELV AG rapid test reflects this biological difference, which is why timing matters.
What should I do if my cat tests positive on the FIV AB + FELV AG rapid test?
A positive result should be discussed with a veterinarian rather than acted on in isolation. Confirmatory testing, including PCR in some cases, helps establish the true status. Positive cats should be kept separate from uninfected cats and monitored with regular health checks. Early nutritional, dental, and stress-management support can meaningfully improve quality of life.
Can the FIV AB + FELV AG rapid test distinguish between infection and vaccination?
The test cannot reliably distinguish vaccine-induced FIV antibodies from those produced by natural infection. That limitation is inherent to antibody-based FIV AB testing, not specific to this product. Antigen-based FELV AG detection does not have the same problem, because vaccines do not produce circulating antigen. Clinicians should combine test results with vaccination history and, when needed, PCR confirmation.
Is a whole blood sample acceptable for the FIV AB + FELV AG rapid test?
Yes, whole blood is an accepted sample type, along with plasma and serum. Whole blood is convenient in point-of-care settings because it avoids a centrifugation step. The supplied anticoagulant tube helps prevent clotting during transfer to the device. Following the exact fill and dilution instructions is essential for accurate FIV AB and FELV AG results.
How accurate is the FIV AB + FELV AG rapid test compared with laboratory testing?
Reputable lateral-flow assays for FIV AB and FELV AG demonstrate high sensitivity and specificity when used correctly. They are designed for screening, and a positive result may still warrant confirmation with a laboratory method. Reference laboratory testing can provide additional detail, especially in ambiguous cases. The FIV AB + FELV AG rapid test is best understood as a fast, reliable first-line screening tool.
How should shelters use the FIV AB + FELV AG rapid test?
Shelters typically test every cat at intake to inform housing and quarantine decisions. Combined testing keeps the process efficient when large numbers of animals are processed in one day. Cats with positive results should be cohorted away from negative cats and retested according to protocol. Clear documentation of FIV AB and FELV AG results supports adoption counseling and reduces transmission risk.
Where can I buy the FIV AB + FELV AG rapid test from Quicking Biotech?
Product details, bulk orders, and distributor inquiries are handled through Quicking Biotech Co., Ltd directly. Clinics can review the veterinary catalog and contact the company through its inquiry channels. Technical documentation and training support are available for partners. Purchasing through the manufacturer ensures product authenticity and consistent lot-to-lot performance.
What is the difference between FIV AB and FELV AG testing?
FIV AB testing detects the host's antibody response to feline immunodeficiency virus. FELV AG testing detects viral antigen, which indicates active feline leukemia virus infection. These two mechanisms explain why the assays are combined on a single device rather than duplicated. Understanding the difference helps clinicians interpret each line on the FIV AB + FELV AG rapid test correctly.
Contact
Leave your information and we will contact you.
